These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16145306)

  • 41. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
    Lacut K; Oger E; Abalain JH; Moineau MP; Mottier D;
    Atherosclerosis; 2004 May; 174(1):173-80. PubMed ID: 15135267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index.
    Jackson S; Vyas S
    Br J Obstet Gynaecol; 1998 Apr; 105(4):408-12. PubMed ID: 9609267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Am J Obstet Gynecol; 2000 Sep; 183(3):575-82. PubMed ID: 10992176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy.
    Cagnacci A; Arangino S; Angiolucci M; Melis GB; Facchinetti F; Malmusi S; Volpe A
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):261-6. PubMed ID: 11207642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
    Cayan F; Dilek U; Pata O; Dilek S
    J Sex Med; 2008 Jan; 5(1):132-8. PubMed ID: 17961145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules.
    Van Baal WM; Emeis JJ; Kenemans P; Kessel H; Peters-Muller ER; Schalkwijk CG; van der Mooren MJ; Stehouwer CD
    Eur J Clin Invest; 1999 Nov; 29(11):913-21. PubMed ID: 10583435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease.
    Seljeflot I; Arnesen H; Hofstad AE; Os I
    Thromb Haemost; 2000 Jun; 83(6):944-8. PubMed ID: 10896253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women.
    Farzati A; Esposito K; Colacurci N; Fornaro F; Chiantera V; Farzati B
    Fertil Steril; 2002 Mar; 77(3):476-80. PubMed ID: 11872198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease.
    Blümel JE; Castelo-Branco C; Leal T; Gallardo L; Saini J; Ferron S; Haya J
    Climacteric; 2003 Mar; 6(1):38-44. PubMed ID: 12725663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
    Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients.
    Persico N; Mancini F; Artini PG; de Iaco P; Volpe A; de Aloysio D; Battaglia C
    Ultrasound Obstet Gynecol; 2005 Oct; 26(5):546-51. PubMed ID: 16184506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow.
    Cacciatore B; Paakkari I; Toivonen J; Tikkanen MJ; Ylikorkala O
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):563-8. PubMed ID: 9764629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral administration of 17beta-estradiol over 3 months without progestin co-administration does not improve coronary flow reserve in post-menopausal women: a randomized placebo-controlled cross-over CMR study.
    Schwitter J; Kozerke S; Bremerich J; Baltes C; Attenhofer Jost C; Birkhäuser M; Boesiger P; Buser P
    J Cardiovasc Magn Reson; 2007; 9(4):665-72. PubMed ID: 17578722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women.
    Noé G; Sitruk-Ware R; Zegers-Hochschild F; Variano B; Montero JC; Arriagada P; Li A; Stanczyk FZ; Felix JC; Mishell DR; Croxatto HB
    Climacteric; 2010 Oct; 13(5):433-41. PubMed ID: 20642326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.